Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2009 Aug 14;28433:22123-22132. doi: 10.1074/jbc.M109.023713.
Show Gene links
Show Anatomy links
Identification of a disulfide bridge essential for transport function of the human proton-coupled amino acid transporter hPAT1.
Dorn M
,
Weiwad M
,
Markwardt F
,
Laug L
,
Rudolph R
,
Brandsch M
,
Bosse-Doenecke E
.
???displayArticle.abstract???
The proton-coupled amino acid transporter 1 (PAT1, SLC36A1) mediates the uptake of small neutral amino acids at the apical membrane of intestinal epithelial cells after protein digestion. The transporter is currently under intense investigation, because it is a possible vehicle for oral drug delivery. Structural features of the protein such as the number of transmembrane domains, the substrate binding site, or essential amino acids are still unknown. In the present study we use mutagenesis experiments and biochemical approaches to determine the role of the three putative extracellular cysteine residues on transport function and their possible involvement in the formation of a disulfide bridge. As treatment with the reducing reagent dithiothreitol impaired transport function of hPAT1 wild type protein, substitution of putative extracellular cysteine residues Cys-180, Cys-329, and Cys-473 by alanine or serine was performed. Replacement of the two highly conserved cysteine residues Cys-180 and Cys-329 abolished the transport function of hPAT1 in Xenopus laevis oocytes. Studies of wild type and mutant transporters expressed in human retinal pigment epithelial (HRPE) cells suggested that the binding of the substrate was inhibited in these mutants. Substitution of the third putative extracellular nonconserved cysteine residue Cys-473 did not affect transport function. All mutants were expressed at the plasma membrane. Biotinylation of free sulfhydryl groups using maleimide-PEG(11)-biotin and SDS-PAGE analysis under reducing and nonreducing conditions provided direct evidence for the existence of an essential disulfide bond between Cys-180 and Cys-329. This disulfide bridge is very likely involved in forming or stabilizing the substrate binding site.
Anderson,
H+/amino acid transporter 1 (PAT1) is the imino acid carrier: An intestinal nutrient/drug transporter in human and rat.
2004, Pubmed,
Xenbase
Anderson,
H+/amino acid transporter 1 (PAT1) is the imino acid carrier: An intestinal nutrient/drug transporter in human and rat.
2004,
Pubmed
,
Xenbase
Asaka,
Identification of essential histidine and cysteine residues of the H+/organic cation antiporter multidrug and toxin extrusion (MATE).
2007,
Pubmed
Blakely,
Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters.
1991,
Pubmed
Boll,
Substrate recognition by the mammalian proton-dependent amino acid transporter PAT1.
2003,
Pubmed
,
Xenbase
Boll,
A cluster of proton/amino acid transporter genes in the human and mouse genomes.
2003,
Pubmed
,
Xenbase
Boll,
Functional characterization of two novel mammalian electrogenic proton-dependent amino acid cotransporters.
2002,
Pubmed
,
Xenbase
Brandsch,
Transport of L-proline, L-proline-containing peptides and related drugs at mammalian epithelial cell membranes.
2006,
Pubmed
Bretschneider,
Drug-dependent ion channel gating by application of concentration jumps using U-tube technique.
1999,
Pubmed
Bröer,
Iminoglycinuria and hyperglycinuria are discrete human phenotypes resulting from complex mutations in proline and glycine transporters.
2008,
Pubmed
Chen,
Structure, function and immunolocalization of a proton-coupled amino acid transporter (hPAT1) in the human intestinal cell line Caco-2.
2003,
Pubmed
Chen,
Direct evidence that two cysteines in the dopamine transporter form a disulfide bond.
2007,
Pubmed
Chen,
External cysteine residues in the serotonin transporter.
1997,
Pubmed
Cook,
An intramolecular disulfide bond between conserved extracellular cysteines in the gonadotropin-releasing hormone receptor is essential for binding and activation.
1997,
Pubmed
Dorn,
The role of N-glycosylation in transport function and surface targeting of the human solute carrier PAT1.
2009,
Pubmed
,
Xenbase
Foltz,
Kinetics of bidirectional H+ and substrate transport by the proton-dependent amino acid symporter PAT1.
2005,
Pubmed
,
Xenbase
Frändberg,
Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
2001,
Pubmed
Fredriksson,
The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.
2008,
Pubmed
Gagnon,
Identification of a disulfide bridge linking the fourth and the seventh extracellular loops of the Na+/glucose cotransporter.
2006,
Pubmed
,
Xenbase
Hebert,
Cholate-solubilized erythrocyte glucose transporters exist as a mixture of homodimers and homotetramers.
1991,
Pubmed
Henriksen,
Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.
2005,
Pubmed
Jess,
The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein.
1996,
Pubmed
Kage,
Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2.
2005,
Pubmed
Karnik,
Cysteine residues 110 and 187 are essential for the formation of correct structure in bovine rhodopsin.
1988,
Pubmed
Klapperstück,
Characteristics of P2X7 receptors from human B lymphocytes expressed in Xenopus oocytes.
2000,
Pubmed
,
Xenbase
Lambert,
Cleavage of disulfide bonds leads to inactivation and degradation of the type IIa, but not type IIb sodium phosphate cotransporter expressed in Xenopus laevis oocytes.
2000,
Pubmed
,
Xenbase
Larsen,
Transport of amino acids and GABA analogues via the human proton-coupled amino acid transporter, hPAT1: characterization of conditions for affinity and transport experiments in Caco-2 cells.
2008,
Pubmed
Metzner,
Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
2004,
Pubmed
Metzner,
Serotonin, L-tryptophan, and tryptamine are effective inhibitors of the amino acid transport system PAT1.
2005,
Pubmed
,
Xenbase
Metzner,
Mutational analysis of histidine residues in the human proton-coupled amino acid transporter PAT1.
2008,
Pubmed
Pajor,
Cysteine residues in the Na+/dicarboxylate co-transporter, NaDC-1.
1999,
Pubmed
,
Xenbase
Riedel,
Kinetics of P2X7 receptor-operated single channels currents.
2007,
Pubmed
,
Xenbase
Sagné,
Identification and characterization of a lysosomal transporter for small neutral amino acids.
2001,
Pubmed
Sturm,
Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinity.
2007,
Pubmed
,
Xenbase
Sur,
The rat serotonin transporter: identification of cysteine residues important for substrate transport.
1997,
Pubmed
Thwaites,
Deciphering the mechanisms of intestinal imino (and amino) acid transport: the redemption of SLC36A1.
2007,
Pubmed
Thwaites,
H(+)-coupled (Na(+)-independent) proline transport in human intestinal (Caco-2) epithelial cell monolayers.
1993,
Pubmed
Turner,
Evidence for two disulfide bonds important to the functioning of the renal outer cortical brush-border membrane D-glucose transporter.
1983,
Pubmed
Wakabayashi,
Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.
2007,
Pubmed
Zottola,
Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization.
1995,
Pubmed
